BRPI0816157A2 - compostos adrenérgicos - Google Patents

compostos adrenérgicos

Info

Publication number
BRPI0816157A2
BRPI0816157A2 BRPI0816157A BRPI0816157A BRPI0816157A2 BR PI0816157 A2 BRPI0816157 A2 BR PI0816157A2 BR PI0816157 A BRPI0816157 A BR PI0816157A BR PI0816157 A BRPI0816157 A BR PI0816157A BR PI0816157 A2 BRPI0816157 A2 BR PI0816157A2
Authority
BR
Brazil
Prior art keywords
adrenergic compounds
adrenergic
compounds
Prior art date
Application number
BRPI0816157A
Other languages
English (en)
Inventor
W Gil Daniel
Chow Ken
E Garst Michael
C Sinha Santosh
S Bhat Smita
M Heidelbaugh Todd
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0816157A2 publication Critical patent/BRPI0816157A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0816157A 2007-08-15 2008-08-14 compostos adrenérgicos BRPI0816157A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95596007P 2007-08-15 2007-08-15
PCT/US2008/073094 WO2009023752A1 (en) 2007-08-15 2008-08-14 Adrenergic compounds

Publications (1)

Publication Number Publication Date
BRPI0816157A2 true BRPI0816157A2 (pt) 2017-06-13

Family

ID=39926497

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816157A BRPI0816157A2 (pt) 2007-08-15 2008-08-14 compostos adrenérgicos

Country Status (11)

Country Link
US (1) US8486969B2 (pt)
EP (1) EP2190835B1 (pt)
JP (1) JP5433576B2 (pt)
KR (1) KR101642520B1 (pt)
CN (1) CN101821254B (pt)
AU (1) AU2008286818B2 (pt)
BR (1) BRPI0816157A2 (pt)
CA (1) CA2696314C (pt)
ES (1) ES2396269T3 (pt)
RU (1) RU2491284C2 (pt)
WO (1) WO2009023752A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256755A (en) * 1980-04-28 1981-03-17 E. I. Du Pont De Nemours & Company Method of using N-substituted dihydro-2-oxazolamines as analgesics
GB8610909D0 (en) * 1986-05-03 1986-06-11 Beecham Group Plc Compounds
US5034406A (en) * 1989-09-26 1991-07-23 Allergan, Inc. Method for reducing or maintaining intraocular pressure
US5077292A (en) * 1989-10-12 1991-12-31 Allergan, Inc. (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
ES2160700T3 (es) * 1994-01-24 2001-11-16 Allergan Sales Inc Derivados aromaticos de 2-amino-imidazol como agonistas del adrenorreceptor alfa-2a.
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
US5866579A (en) * 1997-04-11 1999-02-02 Synaptic Pharmaceutical Corporation Imidazole and imidazoline derivatives and uses thereof
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
US7091232B2 (en) * 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
GB0516706D0 (en) * 2005-08-15 2005-09-21 Syngenta Participations Ag Chemical compounds
EP2014168A1 (de) * 2007-06-19 2009-01-14 Bayer CropScience AG Insektizide heterocyclische Verbindungen

Also Published As

Publication number Publication date
AU2008286818A1 (en) 2009-02-19
RU2010108385A (ru) 2011-09-20
CA2696314C (en) 2016-01-19
WO2009023752A1 (en) 2009-02-19
RU2491284C2 (ru) 2013-08-27
AU2008286818B2 (en) 2014-03-27
EP2190835A1 (en) 2010-06-02
JP2010536778A (ja) 2010-12-02
JP5433576B2 (ja) 2014-03-05
ES2396269T3 (es) 2013-02-20
EP2190835B1 (en) 2012-10-03
KR20100061803A (ko) 2010-06-09
CN101821254A (zh) 2010-09-01
US8486969B2 (en) 2013-07-16
CA2696314A1 (en) 2009-02-19
US20110039864A1 (en) 2011-02-17
KR101642520B1 (ko) 2016-07-25
CN101821254B (zh) 2013-10-09

Similar Documents

Publication Publication Date Title
BRPI0813500A2 (pt) Compostos antivirais
BRPI0821086A2 (pt) Compostos inseticidas
DK2185567T3 (da) Substituerede bicyclolactam-forbindelser
BRPI0815042A2 (pt) Compostos de pirazol
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt) compostos
DK2242759T3 (da) Forbindelser
BRPI0811264A2 (pt) Compostos
BRPI0821627A2 (pt) Compostos químicos
EP2114315A4 (en) Arm prosthetic device
BRPI0814601A2 (pt) compostos químicos
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
BRPI0809996A2 (pt) Compostos
BRPI0814424A2 (pt) Compostos heterociclila
DK2297162T3 (da) Forbindelser
AT505058A3 (de) Türschliesssystem
BRPI0814411A2 (pt) Compostos químicos
BRPI0916432A2 (pt) compostos
EP2208322A4 (en) GRID ROUTER
BRPI0815181A2 (pt) Compostos
DK2206698T3 (da) Ethynylindolforbindelser
BRPI0814613A2 (pt) Compostos
PL3825306T3 (pl) Związki morfinanu
BRPI0922152A2 (pt) Compostos
BRPI0808129A2 (pt) Compostos químicos

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]